How to design OT-2 protocols: Opentrons API

ON-DEMAND WEBINAR

HeaterShaker-6-22--06

Watch the first installment of our webinar tutorial series: How to Design OT-2 Protocols. This series will cover the different ways users can create protocols, whether you’re an automation newbie or experienced Python coder.

 

In this installment, you’ll learn how to create protocols with the Opentrons Python API. This powerful tool gives you ultimate control over your workflows.

 

Sign up to receive this 60-minute webinar to learn:

  • The different ways to create protocols on the Opentrons OT-2
  • Everything you need to know about the Opentrons Python API
  • How to write protocols from scratch or modify existing protocols

Who should watch:

Anyone looking to understand more about the powerful Opentrons Python API:

  • New OT-2 users or anyone interested in becoming an OT-2 user
  • Current OT-2 users transitioning to use Opentrons Python API
  • Scientists and Automation Engineers wanting to learn more about using Python for automating their liquid handling protocols

Access the Webinar Now

Subject to your consent given above, by clicking on "register", Opentrons may share your personal information to communicate with you for marketing purposes, including information about this topic, promotional offers and news. This use of your personal information is an exception to our Privacy Policy.

Speakers

 

A38F6C1D-2B5C-4EB1-8E9F-52CBC474500D_1_201_aNick Diehl

Field Application Scientist, Opentrons

 

 

Nick graduated from Vanderbilt University with a Biomedical Engineering degree in 2018 and joined the Opentrons Applications Engineering team in 2019. Nick has delivered bespoke solutions to hundreds of laboratories and DIY biologists around the world to automate their unique workflows on the Opentrons platform.

 

 

lisetteLissette Bouza, M.S.

Account Manager, Opentrons

 

 

 

 

Lissette earned an M.S. in Molecular Biology from Seton Hall University in 2018. She joined Opentrons in 2020 after working as a research scientist with a focus on testing the effects of novel drugs on specific cancer cell lines.

 

Originally Aired 02/01/23